Form 4: Prestige Consumer Healthcare Director Byom Receives Restricted Stock Units

Director John E. Byom acquired 2,202 restricted stock units of Prestige Consumer Healthcare Inc. on August 6, 2024, as part of the company's director compensation program.

Summary

• On August 6, 2024, John E. Byom, a director of Prestige Consumer Healthcare Inc., received 2,202 restricted stock units.
• These units were granted as part of the Issuer's director compensation program.
• The value of the restricted stock units is $150,000, calculated using a closing stock price of $68.13 on August 6, 2024.
• The restricted stock units vest on the first anniversary of the grant.
• Upon vesting, each unit will be settled by delivering one share of Prestige Consumer Healthcare Inc.'s common stock to Mr. Byom.
• Settlement will occur promptly following the earliest of Mr. Byom's death, separation from the company, or a change in control.

Sentiment

Score: 7

Explanation: The document reflects a routine transaction related to director compensation, which is generally viewed neutrally to positively as it aligns interests. The sentiment is moderately positive.

Positives

• The grant of restricted stock units aligns the director's interests with those of the shareholders.
• The vesting schedule encourages continued service and commitment to the company.

Future Outlook

The restricted stock units will vest on the first anniversary of the grant and will be settled by delivery of common stock upon certain events.

Industry Context

Director compensation packages often include restricted stock units to align the interests of directors with those of shareholders and to incentivize long-term value creation.

Stakeholder Impact

• Shareholders may view the grant of restricted stock units positively as it aligns the director's interests with the company's long-term performance.

Key Dates